IRD vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

IRD

37.8
AI Score
VS
CLYM Wins

CLYM

41.4
AI Score

Investment Advisor Scores

IRD

38score
Recommendation
SELL

CLYM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IRD CLYM Winner
Net Income -49.59M -27.22M CLYM
Operating Income -38.60M -30.57M CLYM
ROE -323.1% -11.4% CLYM
ROA -98.7% -11.1% CLYM
Total Assets 50.24M 246.29M CLYM
Cash 45.09M 44.11M IRD
Current Ratio 6.43 31.45 CLYM

Relative Price Performance (Last 90 Days)

IRD 1M: +60.6% · 3M: +54.5% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

IRD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 77

RSI (14): 76.8 · Price: $6.04

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric IRD CLYM
Market Cap
Forward P/E -8.2 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth -0.7% 0.0%
Gross Margin -2.9%
Operating Margin -21.8% 0.0%
EPS -1.37 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.